Stage IC3 Ovarian Adjuvant — SCE Medical Oncology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — 6 cycles of carboplatin + paclitaxel
Stage IC3 (positive peritoneal washings) high-grade serous ovarian cancer has approximately 25-35% recurrence risk requiring adjuvant chemotherapy (6 cycles carboplatin-paclitaxel). The distinction between IC1 (intra-operative rupture), IC2 (pre-operative rupture) and IC3 (positive washings) affects prognosis — IC3 has the worst outlook. After completing chemotherapy, PARP inhibitor maintenance eligibility depends on BRCA/HRD testing per standard algorithms. The ICON1 trial supports adjuvant chemotherapy for high-risk early ovarian cancer.
Reference: https://www.nice.org.uk/guidance/conditions-and-diseases/cancer